346 related articles for article (PubMed ID: 16373258)
21. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.
Finckh A; Berner IC; Aubry-Rozier B; So AK
J Rheumatol; 2005 Jul; 32(7):1336-40. PubMed ID: 15996074
[TBL] [Abstract][Full Text] [Related]
22. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
Sánchez-Guerrero J; Fragoso-Loyo HE; Neuwelt CM; Wallace DJ; Ginzler EM; Sherrer YR; McIlwain HH; Freeman PG; Aranow C; Petri MA; Deodhar AA; Blanton E; Manzi S; Kavanaugh A; Lisse JR; Ramsey-Goldman R; McKay JD; Kivitz AJ; Mease PJ; Winkler AE; Kahl LE; Lee AH; Furie RA; Strand CV; Lou L; Ahmed M; Quarles B; Schwartz KE
J Rheumatol; 2008 Aug; 35(8):1567-75. PubMed ID: 18634158
[TBL] [Abstract][Full Text] [Related]
23. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women.
Kenny AM; Boxer RS; Kleppinger A; Brindisi J; Feinn R; Burleson JA
J Am Geriatr Soc; 2010 Sep; 58(9):1707-14. PubMed ID: 20863330
[TBL] [Abstract][Full Text] [Related]
24. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
Straub RH; Härle P; Yamana S; Matsuda T; Takasugi K; Kishimoto T; Nishimoto N
Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
[TBL] [Abstract][Full Text] [Related]
25. Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.
Lebrun CE; van der Schouw YT; de Jong FH; Pols HA; Grobbee DE; Lamberts SW
Maturitas; 2006 Aug; 55(1):82-92. PubMed ID: 16497451
[TBL] [Abstract][Full Text] [Related]
26. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
[TBL] [Abstract][Full Text] [Related]
27. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
28. Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus.
Suzuki N; Suzuki T; Sakane T
Ann Med Interne (Paris); 1996; 147(4):248-52. PubMed ID: 8952743
[TBL] [Abstract][Full Text] [Related]
29. The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus.
Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
Arthritis Rheum; 2004 Nov; 50(11):3591-5. PubMed ID: 15529389
[TBL] [Abstract][Full Text] [Related]
30. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
32. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa.
Gordon CM; Grace E; Emans SJ; Goodman E; Crawford MH; Leboff MS
J Bone Miner Res; 1999 Jan; 14(1):136-45. PubMed ID: 9893076
[TBL] [Abstract][Full Text] [Related]
33. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement.
Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
J Clin Endocrinol Metab; 2006 Oct; 91(10):3773-9. PubMed ID: 16849414
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
[TBL] [Abstract][Full Text] [Related]
35. [Focus on dehydroepiandrosterone (DHEA)].
Meyer P; Meier CA
Rev Med Suisse; 2005 Feb; 1(6):415-8. PubMed ID: 15786645
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.
Grootscholten C; Snoek FJ; Bijl M; van Houwelingen HC; Derksen RH; Berden JH;
J Rheumatol; 2007 Aug; 34(8):1699-707. PubMed ID: 17659757
[TBL] [Abstract][Full Text] [Related]
37. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
Genazzani AR; Pluchino N; Begliuomini S; Stomati M; Bernardi F; Pieri M; Casarosa E; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
[TBL] [Abstract][Full Text] [Related]
38. [DHEA: orthodox or alternative medicine?].
Cogan E
Rev Med Brux; 2001 Sep; 22(4):A381-6. PubMed ID: 11680205
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
van Vollenhoven RF; Park JL; Genovese MC; West JP; McGuire JL
Lupus; 1999; 8(3):181-7. PubMed ID: 10342710
[TBL] [Abstract][Full Text] [Related]
40. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.
Gordon C; Wallace DJ; Shinada S; Kalunian KC; Forbess L; Braunstein GD; Weisman MH
Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]